Cargando…

Location of submacular hemorrhage as a predictor of visual outcome after intravitreal ranibizumab for age-related macular degeneration

PURPOSE: To evaluate the anatomical and functional outcomes in patients with submacular hemorrhage (SMH) due to age-related macular degeneration (AMD) treated with ranibizumab, and to evaluate the potential role of the SMH location in the final outcome after treatment. METHODS: Participants in this...

Descripción completa

Detalles Bibliográficos
Autores principales:	Karagiannis, Dimitrios, Chatziralli, Irini, Kaprinis, Konstantinos, Georgalas, Ilias, Parikakis, Efstratios, Mitropoulos, Panagiotis
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2017
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5679569/ https://www.ncbi.nlm.nih.gov/pubmed/29138543 http://dx.doi.org/10.2147/CIA.S145893

Ejemplares similares

Changing from bevacizumab to ranibizumab in age-related macular degeneration. Is it safe?
por: Karagiannis, Dimitrios A, et al.
Publicado: (2009)

Treatment of myopic choroidal neovascularization with intravitreal ranibizumab injections: the role of age
por: Karagiannis, Dimitrios, et al.
Publicado: (2017)

A case of subretinal neovascularization treated with intravitreal ranibizumab in a patient with idiopathic juxtafoveal retinal telangiectasis
por: Karagiannis, Dimitrios, et al.
Publicado: (2009)

Intravitreal Ranibizumab for Stage IV Proliferative Sickle Cell Retinopathy: A First Case Report
por: Mitropoulos, Panagiotis G., et al.
Publicado: (2014)

Spontaneous Resolution of Long-Standing Macular Detachment due to Optic Disc Pit with Significant Visual Improvement
por: Parikakis, Efstratios A., et al.
Publicado: (2014)

Displacement of submacular hemorrhage associated with age-related macular degeneration using vitrectomy and submacular tPA injection followed by intravitreal ranibizumab
por: Sandhu, Sukhpal Singh, et al.
Publicado: (2010)

Thyroidopathy and Age-Related Macular Degeneration: Is There Any Correlation
por: Chatziralli, Irini, et al.
Publicado: (2017)

Intravitreal ranibizumab in treating extensive traumatic submacular hemorrhage
por: Abdul-Salim, Ismail, et al.
Publicado: (2013)

Long-Term Outcomes following Intravitreal Ranibizumab for Choroidal Neovascularization Related to Nd:YAG Laser Macular Injury: A Case Report
por: Christodoulou, Eleni, et al.
Publicado: (2023)

Dexamethasone Intravitreal Implant in Diabetic Macular Edema: Real-Life Data from a Prospective Study and Predictive Factors for Visual Outcome
por: Chatziralli, Irini, et al.
Publicado: (2017)

The Efficacy of Intravitreal Aflibercept in Submacular Hemorrhage Secondary to Wet Age-related Macular Degeneration
por: Shin, Kyung-Hoon, et al.
Publicado: (2016)

Photodynamic Therapy for Juxtapapillary Retinal Capillary Hemangioma
por: Mitropoulos, Panagiotis G., et al.
Publicado: (2014)

Intravitreal Expansile Gas and Bevacizumab Injection for Submacular Hemorrhage Due to Neovascular Age-related Macular Degeneration
por: Nourinia, Ramin, et al.
Publicado: (2010)

Intravitreal anti-vascular endothelial growth factor monotherapy in age-related macular degeneration with submacular hemorrhage
por: Maruyama-Inoue, Maiko, et al.
Publicado: (2023)

Toric Intraocular Lens Implantation for Correction of Astigmatism in Cataract Patients with Corneal Ectasia
por: Parikakis, Efstratios A., et al.
Publicado: (2013)

Trapped Pre-Macular Bubble of Octafluoropropane Gas Masquerading as Retained Submacular Perfluorocarbon Liquid
por: Petrou, Petros, et al.
Publicado: (2019)

Alterations in Retinal Vessel Diameters in Patients with Retinal Vein Occlusion before and after Treatment with Intravitreal Ranibizumab
por: Aissopou, Evaggelia, et al.
Publicado: (2023)

Bilateral Multifocal Chorioretinitis and Optic Neuritis due to Epstein-Barr Virus: A Case Report
por: Peponis, Vasileios G., et al.
Publicado: (2012)

The Impact of Non-Steroidal Anti-Inflammatory Agents after Phacoemulsification on Quality of Life: A Randomized Study
por: Chatziralli, Irini P., et al.
Publicado: (2016)

Switching from Intravitreal Ranibizumab to Bevacizumab for Age-Related Macular Degeneration
por: Yamada, Kisaburo, et al.
Publicado: (2011)

Risk factors for breakthrough vitreous hemorrhage after intravitreal anti-VEGF injection in age-related macular degeneration with submacular hemorrhage
por: Shin, Yong-Il, et al.
Publicado: (2018)

Severe hypotony and filtering bleb leak after intravitreal injection of ranibizumab
por: Georgalas, Ilias, et al.
Publicado: (2009)

Submacular Injection of Ranibizumab as a New Surgical Treatment for Refractory Diabetic Macular Edema
por: El-Baha, Samir M., et al.
Publicado: (2019)

Pre-operative intravitreal dexamethasone implant in patients with refractory diabetic macular edema undergoing cataract surgery
por: Kabanarou, Stamatina A., et al.
Publicado: (2020)

Traumatic Submacular Hemorrhage with Macular Hole Repaired by Pneumatic Displacement and Intravitreal t-PA Injection
por: Mehta, Amy A., et al.
Publicado: (2017)

Macular Hole Formation After Intravitreal Ranibizumab Injection in Wet Age-Related Macular Degeneration
por: Mukherjee, Chandoshi, et al.
Publicado: (2015)

One-Year Outcome of Intravitreal Tissue Plasminogen Activator, Ranibizumab, and Gas Injections for Submacular Hemorrhage in Polypoidal Choroidal Vasculopathy
por: Kitagawa, Yorihisa, et al.
Publicado: (2022)

An atypical case of choroidal neovascularization associated with pseudoxanthoma elasticum treated with intravitreal bevacizumab: a case report
por: Karampelas, Michael, et al.
Publicado: (2013)

Retinal Pigment Epithelial Detachment in Age-Related Macular Degeneration
por: Karampelas, Michael, et al.
Publicado: (2020)

Intravitreal aflibercept treatment in eyes with exudative age-related macular degeneration following prior treatment with intravitreal ranibizumab
por: Narayan, Daniel Sanju, et al.
Publicado: (2015)

Predictive factors for non-response to intravitreal ranibizumab treatment in age-related macular degeneration
por: Suzuki, Misa, et al.
Publicado: (2014)

Visual outcome of intravitreal ranibizumab for exudative age-related macular degeneration: timing and prognosis
por: Canan, Handan, et al.
Publicado: (2014)

Subretinal Neovascular Membrane in Wet Age-Related Macular Degeneration Managed With Intravitreal Ranibizumab
por: Sharma, Tanishq S, et al.
Publicado: (2021)

Acute Zonal Occult Outer Retinopathy with Atypical Findings
por: Karagiannis, Dimitrios, et al.
Publicado: (2014)

Vision-Related Quality of Life in Patients With Rhegmatogenous Retinal Detachment Treated With Pars-Plana Vitrectomy: Impact of Gas Tamponade
por: Machairoudia, Genovefa, et al.
Publicado: (2023)

Intravitreal Ranibizumab Versus Intravitreal Ranibizumab Combined with Posterior Subtenon Triamcinolone Acetonide in Diabetic Macular Edema
por: Karatas, Gamze, et al.
Publicado: (2021)

Resolution of vitreomacular traction following intravitreal ranibizumab in cases of ocular toxoplasmosis with choroidal neovascularization
por: Petrou, Petros, et al.
Publicado: (2013)

Intravitreal anti-VEGF monotherapy for thick submacular hemorrhage of less than 1 week duration secondary to neovascular age-related macular degeneration
por: Jain, Sachin, et al.
Publicado: (2013)

Risk factors for breakthrough vitreous hemorrhage after intravitreal tissue plasminogen activator and gas injection for submacular hemorrhage associated with age related macular degeneration
por: Lim, Jun Hyun, et al.
Publicado: (2020)

Intravitreal aflibercept versus intravitreal ranibizumab for the treatment of diabetic macular edema
por: Fouda, Sameh Mosaad, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_9eb4vsmd744eh1712bc49f6dl8